Metabolism of a Thiazole Benzenesulfonamide Derivative, a Potent and Selective Agonist of the Human β3-Adrenergic Receptor, in Rats: Identification of a Novel Isethionic Acid Conjugate-Reference-Cited by-同舟云学术

Metabolism of a Thiazole Benzenesulfonamide Derivative, a Potent and Selective Agonist of the Human β3-Adrenergic Receptor, in Rats: Identification of a Novel Isethionic Acid Conjugate

Published:2002-07-01 Issue:7 Volume:30 Page:778-787
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Tang Wei,Stearns Ralph A.,Miller Randall R.,Ngui Jason S.,Mathvink Robert J.,Weber Ann E.,Kwei Gloria Y.,Strauss John R.,Keohane Carol A.,Doss George A.,Chiu Shuet-Hing L.,Baillie Thomas A.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference26 articles.

1. Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent .beta.-adrenergic agonist virtually specific for .beta.3 receptors. A promising antidiabetic and antiobesity agent

2. Strategies and Potential Molecular Targets for Obesity Treatment

3. BRL 35135, a potent and selective atypical Î²-adrenoceptor agonist.;Cawthorne;Am J Clin Nutr,1992

4. Genetic variation in the Î²3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity.;Clement;N Engl J Med,1995

5. Obesity and diabetes and the beta-3 adrenergic receptor

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. β 3 -AR Agonists for the Treatment of Overactive Bladder;Comprehensive Medicinal Chemistry III;2017

2. Discovery of Vibegron: A Potent and Selective β3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder;Journal of Medicinal Chemistry;2016-01-08

3. Design, Synthesis, and Evaluation of Conformationally Restricted Acetanilides as Potent and Selective β3Adrenergic Receptor Agonists for the Treatment of Overactive Bladder;Journal of Medicinal Chemistry;2014-02-05

4. A P-gp vesicular transport inhibition assay – Optimization and validation for drug–drug interaction testing;European Journal of Pharmaceutical Sciences;2013-07

5. Predicting the oral absorption of a poorly soluble, poorly permeable weak base using biorelevant dissolution and transfer model tests coupled with a physiologically based pharmacokinetic model;European Journal of Pharmaceutics and Biopharmaceutics;2012-09